Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination dietary supplement containing vitamin A, vitamin D (often as D3), and docosahexaenoic acid (DHA), an omega-3 fatty acid. It is primarily used to treat or prevent deficiencies of these nutrients before, during, and after pregnancy. The combination supports maternal health and fetal development—vitamin A is essential for vision and immune function; vitamin D aids calcium absorption and bone health; DHA supports brain and eye development in the fetus. These supplements are often marketed as prenatal vitamins but may also be used in other populations at risk of deficiency. Mechanistically: - Vitamin A acts mainly through retinoid receptors to regulate gene expression. - Vitamin D acts via the vitamin D receptor to modulate calcium/phosphate metabolism. - DHA incorporates into cell membranes (especially neural tissue) affecting membrane fluidity/function and has anti-inflammatory effects[1][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on vitamin a + vitamin d + docosahexaenoic acid.